News & Updates
Filter by Specialty:

Antihypertensive drugs tied to HCC risk in MASLD with cirrhosis
Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and cirrhosis who are taking antihypertensive medications, including calcium channel blockers (CCBs) and angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs), are at increased risk of developing hepatocellular carcinoma (HCC), suggests a study.
Antihypertensive drugs tied to HCC risk in MASLD with cirrhosis
27 Nov 2024
Hypo-, hyperthyroidism causally linked to pre-eclampsia
Hyper- and hypothyroidism are causally associated with pre-eclampsia (PE), but PE does not causally influence thyroid dysfunctions, suggest the results of a Mendelian randomization (MR) study.
Hypo-, hyperthyroidism causally linked to pre-eclampsia
27 Nov 2024
14-day AF screening no better than usual care in stroke prevention
Use of a 14-day continuous electrocardiographic monitor to screen for atrial fibrillation (AF) in older adults seen in primary care practices does not seem to result in fewer hospitalizations for stroke when compared with usual care, reports a recent study.
14-day AF screening no better than usual care in stroke prevention
22 Nov 2024
ARBs a good alternative to ACEIs in patients with acute MI
The incidence of death is comparable between patients with acute myocardial infarction (MI) without heart failure (HF) receiving angiotensin II receptor blockers (ARBs) and those taking angiotensin-converting enzyme inhibitors (ACEIs), a study has shown.
ARBs a good alternative to ACEIs in patients with acute MI
20 Nov 2024
SGLT-2 inhibitors help avert death in patients with HFrEF
Use of SGLT-2 inhibitors may reduce the risk of all-cause and cardiovascular (CV) mortality in patients with heart failure (HF) with reduced ejection fraction (HFrEF), reports a study.
SGLT-2 inhibitors help avert death in patients with HFrEF
19 Nov 2024
Fruit, vegetable diet a viable treatment for hypertension
A diet that is rich in fruits and vegetables can help treat individuals with primary hypertension by preventing chronic kidney disease (CKD) progression and reducing the risk of cardiovascular disease (CVD), suggest the results of a recent study.